- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Fluticasone 500 & salmeterol and Aclidinium bromide
Total 405 results
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
-
Daewoong Pharmaceutical Co. LTD.Completed
-
University of DundeeAstraZeneca; NHS TaysideCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaCompleted
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
AstraZenecaCompletedA Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)Andorra, Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United Kingdom
-
AstraZenecaMenarini GroupCompletedPulmonary Disease, Chronic ObstructiveItaly, Spain, United Kingdom, Germany, Hungary
-
AstraZenecaCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Argentina, Australia, Canada, Mexico, New Zealand, South Africa
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Belgium, Germany
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Bulgaria, Canada, Czech Republic, France, Germany, Hungary, Italy, Lithuania, Netherlands, Poland, South Africa, Spain, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
GlaxoSmithKlineCompleted
-
AstraZenecaRTI Health SolutionsRecruitingPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
Henan University of Traditional Chinese MedicineJiangsu Famous Medical Technology Co., Ltd.UnknownPulmonary Disease, Chronic ObstructiveChina
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Canada, Korea, Republic of
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Korea, Republic of, Chile, Poland, Czech Republic
-
Neutec Ar-Ge San ve Tic A.ŞCompleted
-
Arthur F Gelb MDCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Netherlands, Romania, Italy, Spain, Belgium, Denmark, Estonia, Sweden, Austria, Latvia, United Kingdom, Ukraine, Russian Federation, Greece, Czech Republic, Slovenia, Norway, Lithuania, Slovakia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Respirent Pharmaceuticals Co Ltd.Becro Ltd.Completed
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, Canada, New Zealand
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Sweden, Ukraine, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Russian Federation, Australia, Czech Republic, Poland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveRussian Federation, United States, Estonia, Chile
-
AstraZenecaCompletedEfficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) PatientsChronic Obstructive Pulmonary Disease (COPD)Germany
-
Leiden University Medical CenterGlaxoSmithKline; Academisch Ziekenhuis Groningen; Netherlands Organisation for... and other collaboratorsTerminated
-
Neutec Ar-Ge San ve Tic A.ŞTerminated
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, Canada, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Russian Federation, Spain, Netherlands, Hungary, Denmark, Poland, Czechia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Canada, France, Germany, Italy, Russian Federation, Sweden
-
AstraZenecaParexelCompletedCOPDPhilippines, Vietnam, China, Taiwan, India
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveCanada, United States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic Obstructive
-
GlaxoSmithKlineParexelCompletedAsthmaUnited States, Australia, Poland, Russian Federation, Spain, Ukraine, Germany, Bulgaria, Argentina, Peru, South Africa, Taiwan, Belgium, Italy, Hungary, Korea, Republic of, Austria, Romania, Colombia, Slovakia, United Kingdom, Mexico and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Respirent Pharmaceuticals Co Ltd.Becro Ltd.Recruiting
-
Respirent Pharmaceuticals Co Ltd.Becro Ltd.Completed
-
Neovii BiotechFresenius Biotech North AmericaCompletedOvarian CancerUnited States
-
Nemours Children's ClinicNational Heart, Lung, and Blood Institute (NHLBI)CompletedAsthmaUnited States
-
Respirent Pharmaceuticals Co Ltd.Becro Ltd.Completed
-
University of DundeeCompleted